MediFind found 13 doctor with experience in Relapsed Refractory Multiple Myeloma (RRMM) near Saitama, JP. Of these, 13 are Experienced.
Yasunobu Sekiguchi practices in Saitama, Japan. Mr. Sekiguchi is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Pancreaticoduodenectomy, and Bone Marrow Transplant.
Machiko Kawamura practices in Saitama, Japan. Kawamura is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Their top areas of expertise are Acute Promyelocytic Leukemia, Leukemia, Angioimmunoblastic T-cell Lymphoma, and Acute Myeloid Leukemia (AML).
Hirofumi Kobayashi practices in Saitama, Japan. Kobayashi is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Their top areas of expertise are Gastric Lymphoma, Non-Hodgkin Lymphoma, Acute Promyelocytic Leukemia, and Diffuse Large B-Cell Lymphoma (DLBCL).
Hiroaki Kanda practices in Saitama, Japan. Mr. Kanda is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Liver Cancer, Adult Soft Tissue Sarcoma, Ampullary Cancer, Pancreaticoduodenectomy, and Endoscopic Transnasal Transsphenoidal Surgery.
Makoto Hanai practices in Saitama, Japan. Mr. Hanai is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Cardiac Tamponade, Hairy Cell Leukemia (HCL), and Relapsed Refractory Multiple Myeloma (RRMM).
Tomoya Abe practices in Komuro, Japan. Mr. Abe is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Hairy Cell Leukemia (HCL), Relapsed Refractory Multiple Myeloma (RRMM), Colorectal Cancer, and Stomach Cancer.
Hiroki Tsutsumi practices in Saitama, Japan. Mr. Tsutsumi is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Promyelocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Hairy Cell Leukemia (HCL), and Synovitis.
Daisuke Takei practices in Saitama, Japan. Mr. Takei is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Liver Cancer, Ulcerative Colitis, Hemorrhagic Proctocolitis, Hepatectomy, and Bone Marrow Aspiration.
Toshiaki Takezaki practices in Koshigaya, Japan. Mr. Takezaki is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Acute Lymphoblastic Leukemia (ALL), Urethritis, Leukemia, and Bone Marrow Transplant.
Masahisa Kudo practices in Saitama, Japan. Kudo is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Their top areas of expertise are Hairy Cell Leukemia (HCL), Relapsed Refractory Multiple Myeloma (RRMM), B-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Yu Nishimura practices in Saitama, Japan. Nishimura is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Their top areas of expertise are Gastric Lymphoma, Mediastinal Tumor, Undifferentiated Pleomorphic Sarcoma, B-Cell Lymphoma, and Thymectomy.
Nobuo Maseki practices in Saitama, Japan. Mr. Maseki is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Gastric Lymphoma, Acute Promyelocytic Leukemia, Non-Hodgkin Lymphoma, and B-Cell Lymphoma.
Masahiro Kizaki practices in Saitama, Japan. Mr. Kizaki is rated as an Experienced expert by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
Last Updated: 10/30/2025